ReP USP - Resultado da busca

Artigo de periodico
Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV (2023)
Nardy, Ariane ; Camargo, Camila Tussato Soares ; Oliveira, Yasmim Faustina Castro de ; Silva, Fernanda Cristina da; Almeida, Millena Soares de; Monteiro, Fernanda Rodrigues ; Silva, Brenda Rodrigues ; Amaral, Jônatas Bussador do ; Oliveira, Danielle Bruna Leal de ; Durigon, Edison Luiz ; Scagion, Guilherme Pereira ; Chalup, Vanessa Nascimento ; Candido, Érika Donizetti ; Aguiar, Andressa Simões ; Novo, Neil Ferreira ; Shio, Marina Tiemi ; França, Carolina Nunes ; Nali, Luiz Henrique da Silva ; Bachi, André Luis Lacerda
Source: Vaccines. Unidades: ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, POLIMORFISMO, CITOMEGALOVIRUS, IMUNOGLOBULINAS, SURTOS DE DOENÇAS, COVID-19, INTERFERONS, IDOSOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDY, Ariane et al. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. Vaccines, v. 11, n. 2, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/vaccines11020480. Acesso em: 04 nov. 2024.
APA
Nardy, A., Camargo, C. T. S., Oliveira, Y. F. C. de, Silva, F. C. da, Almeida, M. S. de, Monteiro, F. R., et al. (2023). Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV. Vaccines, 11( 2), 1-18. doi:10.3390/vaccines11020480
NLM
Nardy A, Camargo CTS, Oliveira YFC de, Silva FC da, Almeida MS de, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Durigon EL, Scagion GP, Chalup VN, Candido ÉD, Aguiar AS, Novo NF, Shio MT, França CN, Nali LH da S, Bachi ALL. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV [Internet]. Vaccines. 2023 ; 11( 2): 1-18.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/vaccines11020480
Vancouver
Nardy A, Camargo CTS, Oliveira YFC de, Silva FC da, Almeida MS de, Monteiro FR, Silva BR, Amaral JB do, Oliveira DBL de, Durigon EL, Scagion GP, Chalup VN, Candido ÉD, Aguiar AS, Novo NF, Shio MT, França CN, Nali LH da S, Bachi ALL. Assessment of the interferon-lambda-3 polymorphism in the antibody response to COVID-19 in older adults seropositive for CMV [Internet]. Vaccines. 2023 ; 11( 2): 1-18.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/vaccines11020480
Artigo de periodico
Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection (2023)
Russo, Momtchilo ; Corrêa, Maria Cássia Mendes ; Lins, Bruna Bezerra ; Kersten, Victor; Pernambuco Filho, Paulo Castanho de Almeida ; Martins, Toni Ricardo ; Mendoza, Tânia Regina Tozetto ; Boas, Lucy Santos Vilas ; Gomes, Brisa Moreira; Dati, Lívia Mendonça Munhoz ; Duarte Neto, Amaro Nunes ; Reigado, Gustavo Roncoli ; Frederico, Ana Beatriz T. ; Cunha, Danielle R. de A. de Brito e ; Paula, Anderson Vicente de ; Silva, José Igor Gomes da ; Vasconcelos, Carlos Frederico Alves de ; Alcalde, Felipe Santiago Chambergo ; Dantas, Viviane Abreu Nunes Cerqueira ; Bom, Ana Paula Dinis Ano; Castilho, Leda R. ; Martins, Rodrigo A. P.; Hirata, Mario Hiroyuki ; Mirotti, Luciana
Source: Vaccines. Unidades: ICB, FM, EACH, FCF, BIOTECNOLOGIA
Subjects: IMUNIDADE, CAMUNDONGOS, LIPOSSOMOS, VACINAS VIRAIS, INFECÇÕES POR CORONAVIRUS, COVID-19, ADENOVÍRUS, PROTEÍNAS RECOMBINANTES, GLICOPROTEÍNAS, CAMUNDONGOS, VACINAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUSSO, Momtchilo et al. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection. Vaccines, v. No 2023, n. 11, p. 01-17, 2023Tradução . . Disponível em: http://dx.doi.org/10.3390/vaccines11111732. Acesso em: 04 nov. 2024.
APA
Russo, M., Corrêa, M. C. M., Lins, B. B., Kersten, V., Pernambuco Filho, P. C. de A., Martins, T. R., et al. (2023). Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection. Vaccines, No 2023( 11), 01-17. doi:10.3390/vaccines11111732
NLM
Russo M, Corrêa MCM, Lins BB, Kersten V, Pernambuco Filho PC de A, Martins TR, Mendoza TRT, Boas LSV, Gomes BM, Dati LMM, Duarte Neto AN, Reigado GR, Frederico ABT, Cunha DR de A de B e, Paula AV de, Silva JIG da, Vasconcelos CFA de, Alcalde FSC, Dantas VANC, Bom APDA, Castilho LR, Martins RAP, Hirata MH, Mirotti L. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection [Internet]. Vaccines. 2023 ; No 2023( 11): 01-17.[citado 2024 nov. 04 ] Available from: http://dx.doi.org/10.3390/vaccines11111732
Vancouver
Russo M, Corrêa MCM, Lins BB, Kersten V, Pernambuco Filho PC de A, Martins TR, Mendoza TRT, Boas LSV, Gomes BM, Dati LMM, Duarte Neto AN, Reigado GR, Frederico ABT, Cunha DR de A de B e, Paula AV de, Silva JIG da, Vasconcelos CFA de, Alcalde FSC, Dantas VANC, Bom APDA, Castilho LR, Martins RAP, Hirata MH, Mirotti L. Intranasal liposomal formulation of spike protein adjuvanted with CpG protects and boosts heterologous immunity of hACE2 transgenic mice to SARS-CoV-2 infection [Internet]. Vaccines. 2023 ; No 2023( 11): 01-17.[citado 2024 nov. 04 ] Available from: http://dx.doi.org/10.3390/vaccines11111732
Artigo de periodico
Vaccines against emerging and neglected infectious diseases: an overview (2022)
Vuitika, Larissa ; Syed, Wasim Aluísio Prates ; Silva, Jaqueline Dinis Queiros; Crema, Karin Paola ; Oliveira, Nelson Côrtes de ; Lira, Aline Aparecida de lima ; Lima, Julia Beatriz Menuci ; Câmara, Niels Olsen Saraiva ; Schimke, Lena Friederike ; Marques, Otavio Cabral ; Sadraeian, Mohammad ; Chaves, Lorena C. S. ; Miranda, Gustavo Cabral de
Source: Vaccines. Unidades: ICB, BIOTECNOLOGIA
Subjects: IMUNOLOGIA, VACINAS, DOENÇAS INFECCIOSAS, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VUITIKA, Larissa et al. Vaccines against emerging and neglected infectious diseases: an overview. Vaccines, v. 10, n. 9, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.3390/vaccines10091385. Acesso em: 04 nov. 2024.
APA
Vuitika, L., Syed, W. A. P., Silva, J. D. Q., Crema, K. P., Oliveira, N. C. de, Lira, A. A. de lima, et al. (2022). Vaccines against emerging and neglected infectious diseases: an overview. Vaccines, 10( 9), 1-11. doi:10.3390/vaccines10091385
NLM
Vuitika L, Syed WAP, Silva JDQ, Crema KP, Oliveira NC de, Lira AA de lima, Lima JBM, Câmara NOS, Schimke LF, Marques OC, Sadraeian M, Chaves LCS, Miranda GC de. Vaccines against emerging and neglected infectious diseases: an overview [Internet]. Vaccines. 2022 ; 10( 9): 1-11.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/vaccines10091385
Vancouver
Vuitika L, Syed WAP, Silva JDQ, Crema KP, Oliveira NC de, Lira AA de lima, Lima JBM, Câmara NOS, Schimke LF, Marques OC, Sadraeian M, Chaves LCS, Miranda GC de. Vaccines against emerging and neglected infectious diseases: an overview [Internet]. Vaccines. 2022 ; 10( 9): 1-11.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/vaccines10091385
Artigo de periodico
VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants (2021)
Syed, Wasim Aluisio Prates ; Chaves, Lorena C. S. ; Crema, Karin Paola; Vuitika, Larissa; Lira, Aline ; Cortês, Nelson de Angelis ; Kersten, Victor; Guimarães, Francisco Eduardo Gontijo ; Sadraeian, Mohammad ; Silva, Fernando Luís Barroso da ; Cabral-Marques, Otávio ; Barbuto, José Alexandre Marzagão ; Russo, Momtchilo ; Câmara, Niels Olsen Saraiva ; Miranda, Gustavo Cabral de
Source: Vaccines. Unidades: IFSC, FCFRP, ICB, BIOTECNOLOGIA
Subjects: COVID-19, CORONAVIRUS, VACINAS VIRAIS, IMUNOLOGIA, VARIAÇÃO GENÉTICA, MUTAÇÃO GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SYED, Wasim Aluisio Prates et al. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, v. 9, n. 12, p. 1409-1-1409-17, 2021Tradução . . Disponível em: https://doi.org/10.3390/vaccines9121409. Acesso em: 04 nov. 2024.
APA
Syed, W. A. P., Chaves, L. C. S., Crema, K. P., Vuitika, L., Lira, A., Cortês, N. de A., et al. (2021). VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants. Vaccines, 9( 12), 1409-1-1409-17. doi:10.3390/vaccines9121409
NLM
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/vaccines9121409
Vancouver
Syed WAP, Chaves LCS, Crema KP, Vuitika L, Lira A, Cortês N de A, Kersten V, Guimarães FEG, Sadraeian M, Silva FLB da, Cabral-Marques O, Barbuto JAM, Russo M, Câmara NOS, Miranda GC de. VLP-based COVID-19 vaccines: an adaptable technology against the threat of new variants [Internet]. Vaccines. 2021 ; 9( 12): 1409-1-1409-17.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3390/vaccines9121409

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Subjects

Funding Agencies

Non normalized affiliation